The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!

D Nandi, S Parida, D Sharma - Gut Microbes, 2023 - Taylor & Francis
Regardless of the global progress in early diagnosis and novel therapeutic regimens, breast
carcinoma poses a devastating threat, and the advances are somewhat marred by high …

[HTML][HTML] Breast and gut microbiome in health and cancer

J Zhang, Y Xia, J Sun - Genes & Diseases, 2021 - Elsevier
The microbiota plays essential roles in health and disease, in both the intestine and the
extra-intestine. Dysbiosis of the gut microbiota causes dysfunction in the intestine, which …

[HTML][HTML] Valproic acid and breast cancer: State of the art in 2021

A Wawruszak, M Halasa, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most common cancer diagnosed among women
worldwide. Despite numerous studies, the pathogenesis of BC is still poorly understood, and …

[HTML][HTML] Recent advances in prodrug-based nanoparticle therapeutics

KJ Chen, AJ Plaunt, FG Leifer, JY Kang… - European Journal of …, 2021 - Elsevier
Extensive research into prodrug modification of active pharmaceutical ingredients and
nanoparticle drug delivery systems has led to unprecedented levels of control over the …

Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines

S Kundur, A Prayag, P Selvakumar… - Journal of cellular …, 2019 - Wiley Online Library
Women with the breast cancer type 1 susceptibility protein (BRCA1) mutation and loss of
BRCA1 expression are reported to have an increased risk of triple‐negative breast cancer …

[HTML][HTML] Modulating microbiota as a new strategy for breast cancer prevention and treatment

H Wu, S Ganguly, TO Tollefsbol - Microorganisms, 2022 - mdpi.com
Breast cancer (BC) is the most common cancer in women in the United States. There has
been an increasing incidence and decreasing mortality rate of BC cases over the past …

[HTML][HTML] The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy

I Psilopatis, N Garmpis, A Garmpi, K Vrettou, P Sarantis… - Cancers, 2023 - mdpi.com
Simple Summary Histone deacetylase inhibitors (HDACIs) are a relatively new drug class
with important effects on the epigenetic regulation in cancer, inducing cancer cell death …

[HTML][HTML] Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications

G Sher, NA Salman, AQ Khan, KS Prabhu… - Seminars in cancer …, 2022 - Elsevier
The global burden of breast cancer (BC) is increasing significantly. This trend is caused by
several factors such as late diagnosis, limited treatment options for certain BC subtypes …

Emerging epigenetic‐based nanotechnology for cancer therapy: modulating the tumor microenvironment

J Zhang, L Huang, G Ge, K Hu - Advanced Science, 2023 - Wiley Online Library
Dysregulated epigenetic modifications dynamically drive the abnormal transcription process
to affect the tumor microenvironment; thus, promoting cancer progression, drug resistance …

[HTML][HTML] Recent update and drug target in molecular and pharmacological insights into autophagy modulation in cancer treatment and future progress

MA Rahman, ASM Saikat, MS Rahman, M Islam… - Cells, 2023 - mdpi.com
Recent evidence suggests that autophagy is a governed catabolic framework enabling the
recycling of nutrients from injured organelles and other cellular constituents via a lysosomal …